Tandem Diabetes Care Inc
(STU:TD5A)
€
29.15
-1.65 (-5.36%)
Market Cap: 1.92 Bil
Enterprise Value: 1.92 Bil
PE Ratio: 0
PB Ratio: 8.66
GF Score: 82/100 
Tandem Diabetes Care Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019 / 11:20PM GMT
Release Date Price:
€60.94
(+3.80%)
Travis Lee Steed
BofA Merrill Lynch, Research Division - VP
Travis Steed. I work at the -- on the BofA med tech team. And we have the pleasure for having Kim, John and Leigh all 3 here today from Tandem Diabetes.
Kim D. Blickenstaff
Tandem Diabetes Care, Inc. - Executive Chairman of the Board
The 3 musketeers.
Travis Lee Steed
BofA Merrill Lynch, Research Division - VP
Yes, welcome.
Kim D. Blickenstaff
Tandem Diabetes Care, Inc. - Executive Chairman of the Board
We've been talking since 8:00 this morning so we might not have adequate voice.
Questions & Answers
Travis Lee Steed
BofA Merrill Lynch, Research Division - VP
We can get through this. That's perfectly okay. Well I'm sure we can hear you. I guess I wanted to start off first on Q1 since you just reported recently, came in well above I think anyone's expectations. If you look at, go back and look at Q1 what are -- what's the one or two things that really
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers